Genetics of allergy and allergic sensitization: common variants, rare mutations

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 115-126

  Bønnelykke, Klaus ^a   Sparks, Rachel ^b   Waage, Johannes ^a   Milner, Joshua D ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; AUTOIMMUNITY; CELLULAR IMMUNITY; EPIGENETICS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOGENETICS; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MONOGENIC DISORDER; MUCOSA; PATHOGENESIS; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; SKIN FUNCTION; T LYMPHOCYTE; TH2 CELL; ANIMAL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HYPERSENSITIVITY; IMMUNIZATION; IMMUNOLOGY; MUTATION; PHENOTYPE; QUANTITATIVE TRAIT; QUANTITATIVE TRAIT LOCUS;

ANIMALS; AUTOIMMUNITY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERSENSITIVITY; IMMUNIZATION; MUTATION; PHENOTYPE; QUANTITATIVE TRAIT LOCI; QUANTITATIVE TRAIT, HERITABLE;

EID: 84941912936     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.08.002     Document Type: Review

References (77)

1. Welter D., MacArthur J., Morales J., Burdett T., Hall P., Junkins H., et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014, 42(Database issue):D1001-D1006.
2. Moffatt M.F., Gut I.G., Demenais F., Strachan D.P., Bouzigon E., Heath S., et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010, 363:1211-1221.
3. Moffatt M.F., Kabesch M., Liang L., Dixon A.L., Strachan D., Heath S., et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 2007, 448:470-473.
4. Hao K., Bossé Y., Nickle D.C., Paré P.D., Postma D.S., Laviolette M., et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 2012, 8:e1003029.
5. Worgall T.S., Veerappan A., Sung B., Kim B.I., Weiner E., Bholah R., et al. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci Transl Med 2013, 5:186ra67.
6. Ha S.G., Ge X.N., Bahaie N.S., Kang B.N., Rao A., Rao S.P., et al. ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48. Nat Commun 2013, 4:2479.
7. Traister R.S., Uvalle C.E., Hawkins G.A., Meyers D.A., Bleecker E.R., Wenzel S.E. Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. J Allergy Clin Immunol 2015, 135:92-99.
8. Ho J.E., Chen W.-Y., Chen M.-H., Larson M.G., McCabe E.L., Cheng S., et al. Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling. J Clin Invest 2013, 123:4208-4218.
9. Bønnelykke K., Matheson M.C., Pers T.H., Granell R., Strachan D.P., Alves A.C., et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet 2013, 45:902-906.
10. Hinds D.A., McMahon G., Kiefer A.K., Do C.B., Eriksson N., Evans D.M., et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet 2013, 45:907-911.
11. Ramasamy A., Curjuric I., Coin L.J., Kumar A., McArdle W.L., Imboden M., et al. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol 2011, 128:996-1005.
12. Ezell S.A., Polytarchou C., Hatziapostolou M., Guo A., Sanidas I., Bihani T., et al. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proc Natl Acad Sci U S A 2012, 109:E613-E621.
13. Stockis J., Colau D., Coulie P.G., Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009, 39:3315-3322.
14. BouzigninStockis J., Colau D., Coulie P.G., Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009, 39:3315-3322.
15. Bønnelykke K., Sleiman P., Nielsen K., Kreiner-Møller E., Mercader J.M., Belgrave D., et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 2014, 46:51-55.
16. Esparza-Gordillo J., Weidinger S., Fölster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet 2009, 41:596-601.
17. Ferreira M.A.R., Matheson M.C., Duffy D.L., Marks G.B., Hui J., Le Souëf P., et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet 2011, 378:1006-1014.
18. Rabin R.L., Levinson A.I. The nexus between atopic disease and autoimmunity: a review of the epidemiological and mechanistic literature. Clin Exp Immunol 2008, 153:19-30.
19. Bach J.-F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
20. Farh K.K.-H., Marson A., Zhu J., Kleinewietfeld M., Housley W.J., Beik S., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015, 518:337-343.
21. Jostins L., Ripke S., Weersma R.K., Duerr R.H., McGovern D.P., Hui K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491:119-124.
22. Bochkov Y.A., Watters K., Ashraf S., Griggs T.F., Devries M.K., Jackson D.J., et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A 2015, 112:5485-5490.
23. Torgerson D.G., Ampleford E.J., Chiu G.Y., Gauderman W.J., Gignoux C.R., Graves P.E., et al. Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011, 43:887-892.
24. Israel E., Lasky-Su J., Markezich A., Damask A., Szefler S.J., Schuemann B., et al. Genome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. Am J Respir Crit Care Med 2015, 191:530-537.
25. Igartua C., Myers R.A., Mathias R.A., Pino-Yanes M., Eng C., Graves P.E., et al. Ethnic-specific associations of rare and low-frequency DNA sequence variants with asthma. Nat Commun 2015, 6:5965.
26. Albert F.W., Kruglyak L. The role of regulatory variation in complex traits and disease. Nat Rev Genet 2015, 16:197-212.
27. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
28. Ashley E.A. The precision medicine initiative: a new national effort. JAMA 2015, April.
29. Vu Q.V., Wada T., Toma T., Tajima H., Maeda M., Tanaka R., et al. Clinical and immunophenotypic features of atypical complete DiGeorge syndrome. Pediatr Int 2013, 55:2-6.
30. Selim M.A., Markert M.L., Burchette J.L., Herman C.M., Turner J.W. The cutaneous manifestations of atypical complete DiGeorge syndrome: a histopathologic and immunohistochemical study. J Cutan Pathol 2008, 35:380-385.
31. Villa A., Notarangelo L.D., Roifman C.M. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol 2008, 122:1082-1086.
32. Marrella V., Poliani P.L., Sobacchi C., Grassi F., Villa A. Of Omenn and mice. Trends Immunol 2008, 29:133-140.
33. Felgentreff K., Perez-Becker R., Speckmann C., Schwarz K., Kalwak K., Markelj G., et al. Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency. Clin Immunol (Orlando, FL) 2011, 141:73-82.
34. Lawrence M.G., Barber J.S., Sokolic R.A., Garabedian E.K., Desai A.N., O'Brien M., et al. Elevated IgE and atopy in patients treated for early-onset ADA-SCID. J Allergy Clin Immunol 2013, 132:1444-1446.
35. Yu X., Almeida J.R., Darko S., van der Burg M., DeRavin S.S., Malech H., et al. Human syndromes of immunodeficiency and dysregulation are characterized by distinct defects in T-cell receptor repertoire development. J Allergy Clin Immunol 2014, 133:1109-1115.
36. Sauer A.V., Brigida I., Carriglio N., Hernandez R.J., Scaramuzza S., Clavenna D., et al. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID. Blood 2012, 119:1428-1439.
37. Cassani B., Poliani P.L., Moratto D., Sobacchi C., Marrella V., Imperatori L., et al. Defect of regulatory T cells in patients with Omenn syndrome. J Allergy Clin Immunol 2010, 125:209-216.
38. Sauer A.V., Brigida I., Carriglio N., Aiuti A. Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency. Front Immunol 2012, 3:265.
39. Ombrello M.J., Remmers E.F., Sun G., Freeman A.F., Datta S., Torabi-Parizi P., et al. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions. N Engl J Med 2012, 366:330-338.
40. Aderibigbe O.M., Priel D.L., Lee C.C., Ombrello M.J., Prajapati V.H., Liang M.G., et al. Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2 mutations. JAMA Dermatol 2015, 151:627-634.
41. Frischmeyer-Guerrerio P.A., Guerrerio A.L., Oswald G., Chichester K., Myers L., Halushka M.K., et al. TGFbeta receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med 2013, 5:195ra94.
42. Felgentreff K., Siepe M., Kotthoff S., von Kodolitsch Y., Schachtrup K., Notarangelo L.D., et al. Severe eczema and hyper-IgE in Loeys-Dietz-syndrome-contribution to new findings of immune dysregulation in connective tissue disorders. Clin Immunol (Orlando, FL) 2014, 150:43-50.
43. Farmand S., Sundin M. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care. Curr Opin Hematol 2015, 22:12-22.
44. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 357:1608-1619.
45. Boos A.C., Hagl B., Schlesinger A., Halm B.E., Ballenberger N., Pinarci M., et al. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. Allergy 2014, 69:943-953.
46. Siegel A.M., Stone K.D., Cruse G., Lawrence M.G., Olivera A., Jung M.Y., et al. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol 2013, 132:1388-1396.
47. Erlich T.H., Yagil Z., Kay G., Peretz A., Migalovich-Sheikhet H., Tshori S., et al. Mitochondrial STAT3 plays a major role in IgE-antigen-mediated mast cell exocytosis. J Allergy Clin Immunol 2014, 134:460-469.
48. Zhang Y., Yu X., Ichikawa M., Lyons J.J., Datta S., Lamborn I.T., et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 2014, 133:1400-1409.
49. Stray-Pedersen A., Backe P.H., Sorte H.S., Morkrid L., Chokshi N.Y., Erichsen H.C., et al. PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia. Am J Hum Genet 2014, 95:96-107.
50. Sassi A., Lazaroski S., Wu G., Haslam S.M., Fliegauf M., Mellouli F., et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol 2014, 133:1410-1419.
51. Schnaar R.L. Glycans and glycan-binding proteins in immune regulation: a concise introduction to glycobiology for the allergist. J Allergy Clin Immunol 2015, 135:609-615.
52. Aydin S.E., Kilic S.S., Aytekin C., Kumar A., Porras O., Kainulainen L., et al. DOCK8 deficiency: clinical and immunological phenotype and treatment options-a review of 136 patients. J Clin Immunol 2015, 35:189-198.
53. Zhang Q., Davis J.C., Lamborn I.T., Freeman A.F., Jing H., Favreau A.J., et al. Combined immunodeficiency associated with DOCK8 mutations. N Engl J Med 2009, 361:2046-2055.
54. Ozcan E., Notarangelo L.D., Geha R.S. Primary immune deficiencies with aberrant IgE production. J Allergy Clin Immunol 2008, 122:1054-1062. [quiz 63-4].
55. Thrasher A.J., Burns S.O. WASP: a key immunological multitasker. Nat Rev Immunol 2010, 10:182-192.
56. Ochs H.D., Thrasher A.J. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 2006, 117:725-738.
57. Jing H., Zhang Q., Zhang Y., Hill B.J., Dove C.G., Gelfand E.W., et al. Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype. J Allergy Clin Immunol 2014, 133:1667-1675.
58. Taylor M.D., Sadhukhan S., Kottangada P., Ramgopal A., Sarkar K., D'Silva S., et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med 2010, 2:37ra44.
59. Samuelov L., Sarig O., Harmon R.M., Rapaport D., Ishida-Yamamoto A., Isakov O., et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 2013, 45:1244-1248.
60. Has C., Jakob T., He Y., Kiritsi D., Hausser I., Bruckner-Tuderman L. Loss of desmoglein 1 associated with palmoplantar keratoderma, dermatitis and multiple allergies. Brit J Dermatol 2015, 172:257-261.
61. Samuelov L., Sprecher E. Peeling off the genetics of atopic dermatitis-like congenital disorders. J Allergy Clin Immunol 2014, 134:808-815.
62. Hovnanian A. Netherton syndrome: skin inflammation and allergy by loss of protease inhibition. Cell Tissue Res 2013, 351:289-300.
63. Hannula-Jouppi K., Laasanen S.L., Heikkila H., Tuomiranta M., Tuomi M.L., Hilvo S., et al. IgE allergen component-based profiling and atopic manifestations in patients with Netherton syndrome. J Allergy Clin Immunol 2014, 134:985-988.
64. Fortugno P., Furio L., Teson M., Berretti M., El Hachem M., Zambruno G., et al. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. Hum Mol Genet 2012, 21:4187-4200.
65. Oji V., Eckl K.M., Aufenvenne K., Natebus M., Tarinski T., Ackermann K., et al. Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: unraveling the peeling skin disease. Am J Hum Genet 2010, 87:274-281.
66. Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Investig 2012, 122:440-447.
67. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002, 347:1151-1160.
68. Minegishi Y., Saito M., Nagasawa M., Takada H., Hara T., Tsuchiya S., et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 2009, 206:1291-1301.
69. Barzaghi F., Passerini L., Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol 2012, 3:211.
70. Verbsky J.W., Chatila T.A. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013, 25:708-714.
71. Milner J.D., Vogel T.P., Forbes L., Ma C.A., Stray-Pedersen A., Niemela J.E., et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 2015, 125:591-599.
72. Charbonnier L.M., Janssen E., Chou J., Ohsumi T.K., Keles S., Hsu J.T., et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 2015, 135:217-227.
73. Janssen E., Morbach H., Ullas S., Bannock J.M., Massad C., Menard L., et al. Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. J Allergy Clin Immunol 2014, 134:1365-1374.
74. Wada T., Schurman S.H., Garabedian E.K., Yachie A., Candotti F. Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome. Blood 2005, 106:3895-3897.
75. Heimall J., Davis J., Shaw P.A., Hsu A.P., Gu W., Welch P., et al. Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES). Clin Immunol (Orlando, FL) 2011, 139:75-84.
76. Shearer W.T., Dunn E., Notarangelo L.D., Dvorak C.C., Puck J.M., Logan B.R., et al. Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 2014, 133:1092-1098.
77. McAleer M.A., Pohler E., Smith F.J., Wilson N.J., Cole C., MacGowan S., et al. Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol 2015, [in press]. 10.1016/j.jaci.2015.05.002.